Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Beckmann

Showing results (231-240 of 248) with videos related to

Pageof 25
Sort By:
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Hormone Therapy and its Effect on the Prognosis in Breast Cancer PatientsC Rauh, F Schuetz, B Rack, et al.
Geburtshilfe Und Frauenheilkunde|September 2, 2016
The International Endometriosis Evaluation Program (IEEP Study) - A Systematic Study for Physicians, Researchers and PatientsS Burghaus, T Fehm, P A Fasching, et al.
Acta Psychiatrica Scandinavica|April 7, 2017
Prenatal and adult androgen activities in alcohol dependenceB Lenz, C Mühle, B Braun, et al.
British Journal of Cancer|June 9, 1999
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics ConsortiumV Launonen, K Laake, P Huusko, et al.
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)M Untch, N Harbeck, J Huober, et al.
British Journal of Cancer|August 2, 2012
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2G C Wishart, C D Bajdik, E Dicks, et al.
Breast (Edinburgh, Scotland)|January 21, 2020
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patientsC C Hack, L Häberle, S Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde|January 9, 2015
Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM StudyP A Fasching, T Fehm, S Kellner, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 2018
Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM studyN Nabieva, T Fehm, L Häberle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patientsN Nabieva, S Kellner, T Fehm, et al.
Pageof 25

Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Hormone Therapy and its Effect on the Prognosis in Breast Cancer PatientsC Rauh, F Schuetz, B Rack, et al.
Geburtshilfe Und Frauenheilkunde|September 2, 2016
The International Endometriosis Evaluation Program (IEEP Study) - A Systematic Study for Physicians, Researchers and PatientsS Burghaus, T Fehm, P A Fasching, et al.
Acta Psychiatrica Scandinavica|April 7, 2017
Prenatal and adult androgen activities in alcohol dependenceB Lenz, C Mühle, B Braun, et al.
British Journal of Cancer|June 9, 1999
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics ConsortiumV Launonen, K Laake, P Huusko, et al.
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)M Untch, N Harbeck, J Huober, et al.
British Journal of Cancer|August 2, 2012
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2G C Wishart, C D Bajdik, E Dicks, et al.
Breast (Edinburgh, Scotland)|January 21, 2020
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patientsC C Hack, L Häberle, S Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde|January 9, 2015
Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM StudyP A Fasching, T Fehm, S Kellner, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 2018
Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM studyN Nabieva, T Fehm, L Häberle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patientsN Nabieva, S Kellner, T Fehm, et al.
Pageof 25